Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-07-11
DOI
10.1111/jcmm.13743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose
- (2018) Xiaohui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction
- (2018) Timothy D. Bryson et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling
- (2017) Jin Kyung Kim et al. IMMUNOLOGY AND CELL BIOLOGY
- Gypenoside IX Suppresses p38 MAPK/Akt/NFκB Signaling Pathway Activation and Inflammatory Responses in Astrocytes Stimulated by Proinflammatory Mediators
- (2017) Xiaoshuang Wang et al. INFLAMMATION
- 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway
- (2017) Huili Wei et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
- (2017) Tiantian Tang et al. Nature Communications
- Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling
- (2017) Wei Liu et al. Nature Communications
- Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells
- (2016) Zena Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
- (2016) Manasi S. Shah et al. CIRCULATION RESEARCH
- Hsf4 counteracts Hsf1 transcription activities and increases lens epithelial cell survival in vitro
- (2015) Xiukun Cui et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular mechanisms regulating NLRP3 inflammasome activation
- (2015) Eun-Kyeong Jo et al. Cellular & Molecular Immunology
- Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2
- (2015) Venugopal Rajanbabu et al. CELLULAR IMMUNOLOGY
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression
- (2015) Shui-Xing Yu et al. Scientific Reports
- Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
- (2015) Jacob A Udell et al. Lancet Diabetes & Endocrinology
- Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation
- (2015) Prajwal Gurung et al. Scientific Reports
- TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
- (2014) Yi Liu et al. BASIC RESEARCH IN CARDIOLOGY
- Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson׳s disease
- (2014) Keon Sung Shin et al. BRAIN RESEARCH
- Gypenosides attenuate cholesterol-induced DNA damage by inhibiting the production of reactive oxygen species in human umbilical vein endothelial cells
- (2014) YUAN QUAN et al. Molecular Medicine Reports
- Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
- (2014) Karina Huynh et al. PHARMACOLOGY & THERAPEUTICS
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation
- (2014) J. Fuentes-Antrás et al. International Journal of Endocrinology
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β
- (2012) Nathan A. Bracey et al. EXPERIMENTAL PHYSIOLOGY
- A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?
- (2012) Haitao Wen et al. NATURE IMMUNOLOGY
- Quercetin and Allopurinol Ameliorate Kidney Injury in STZ-Treated Rats with Regulation of Renal NLRP3 Inflammasome Activation and Lipid Accumulation
- (2012) Chuang Wang et al. PLoS One
- Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria
- (2011) Dawn K. Coletta et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- ptx3, a key component of innate immunity, is induced by saa via fprl1-mediated signaling in HAECs
- (2011) Zhe Dong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
- (2011) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Methods in cardiomyocyte isolation, culture, and gene transfer
- (2011) William E. Louch et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
- (2011) Grant R. Drummond et al. NATURE REVIEWS DRUG DISCOVERY
- The Inflammasome in Atherosclerosis and Type 2 Diabetes
- (2011) S. L. Masters et al. Science Translational Medicine
- Critical functions of priming and lysosomal damage for NLRP3 activation
- (2010) Veit Hornung et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
- (2010) Md. Hasan Zaki et al. IMMUNITY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- The NALP3 inflammasome is involved in the innate immune response to amyloid-β
- (2008) Annett Halle et al. NATURE IMMUNOLOGY
- Insight into the inflammasome and caspase-activating mechanisms
- (2007) Olivier Gaide et al. Expert Review of Clinical Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now